One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
Mar 3, 2016
0
0
Oxford University scientists have started a clinical trial to test a new vaccine against prostate cancer and are looking for volunteers to take part. The first four participants have already received this experimental vaccine ...
Feb 29, 2016
0
2
An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa—and the approach could establish a new ...
Feb 12, 2016
0
34
An experimental vaccine to protect against the mosquito-borne illness chikungunya is being tested in a Phase 2 trial sponsored by the National Institutes of Health. Results from an initial trial of the vaccine, which was ...
Nov 24, 2015
0
6
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and their collaborators have developed an experimental, nanoparticle-based vaccine against Epstein-Barr ...
Aug 13, 2015
0
13
Researchers report they are closer to finding a vaccine for respiratory syncytial virus (RSV), a common illness that few recognize by name but one that's a major cause of lower respiratory infection in babies and the elderly.
Aug 12, 2015
0
65
Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable Americans—babies and senior citizens.
Aug 10, 2015
0
36
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...
Jul 28, 2015
0
92
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday.
Jul 28, 2015
0
40
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola. The findings were recently published ...
Jul 13, 2015
0
124
